首页|期刊导航|Oncology Research|GPX4 Defines an Immune-Cold Phenotype and Poor Prognosis in Resected Lung Adenocarcinoma

GPX4 Defines an Immune-Cold Phenotype and Poor Prognosis in Resected Lung Adenocarcinoma

Ganxin Wang Zhongan Liu Tian Zhou Boting Yang Jiaqin Chen Jing Chen Kai Huang Yunqing Xu Quan Tang Xiangqian Yin Guangqin Xiao Sijia Zhang

Oncology Research2026，Vol.34Issue(8)：P.566-589,24.

Oncology Research2026，Vol.34Issue(8)：P.566-589,24.DOI:10.32604/or.2026.083840

GPX4 Defines an Immune-Cold Phenotype and Poor Prognosis in Resected Lung Adenocarcinoma

Ganxin Wang ¹Zhongan Liu ¹Tian Zhou ²Boting Yang ³Jiaqin Chen ³Jing Chen ²Kai Huang ⁴Yunqing Xu ⁴Quan Tang ⁵Xiangqian Yin ⁴Guangqin Xiao ¹Sijia Zhang³

作者信息

1. Cancer Center,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,China
2. Department of Infectious Diseases,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,China
3. Cancer Center,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,China Department of Biophysics,Center for Integrative Physiology and Molecular Medicine(CIPMM),School of Medicine,Saarland University,Homburg,Germany Department of Biomedical Sciences,Institute for Health Research and Education,Osnabrück University,Osnabrück,Germany
4. Department of Oncology,People’s Hospital of Huangpi District,Jianghan University,Wuhan,China
5. Department of Oncology,Hubei Aerospace Hospital,Xiaogan,China
折叠

摘要

关键词

Lung adenocarcinoma/GPX4/tumor immune microenvironment/PD-L1/nomogram

分类

医药卫生

引用本文复制引用

Ganxin Wang,Zhongan Liu,Tian Zhou,Boting Yang,Jiaqin Chen,Jing Chen,Kai Huang,Yunqing Xu,Quan Tang,Xiangqian Yin,Guangqin Xiao,Sijia Zhang..GPX4 Defines an Immune-Cold Phenotype and Poor Prognosis in Resected Lung Adenocarcinoma[J].Oncology Research,2026,34(8):P.566-589,24.

基金项目

supported by grants from the National Natural Science Foundation of China(Nos.81402197,81600482,and 82570789) （Nos.81402197,81600482,and 82570789）

the Natural Science Foundation of Hubei Province(Nos.2019CFB501,2020CFB600,and 2024 AFB663) （Nos.2019CFB501,2020CFB600,and 2024 AFB663）

the China Postdoctoral Science Foundation(Nos.2018M632875 and 2019T120671) （Nos.2018M632875 and 2019T120671）

the China Scholarship Council(CSC)(No.202306160006). （CSC）

Oncology Research

ISSN：0965-0407

访问量0

下载量0

段落导航